LGND vs. CHRW
LGND (Ligand Pharmaceuticals Incorporated) and CHRW (C.H. Robinson Worldwide, Inc.) are both stocks. LGND operates in Biotechnology (Healthcare), while CHRW operates in Integrated Freight & Logistics (Industrials). Over the past 10 years, LGND returned 8.04%/yr vs 10.53%/yr for CHRW. Their 0.26 correlation means their historical movements had little consistent relationship.
Performance
LGND vs. CHRW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LGND achieves a 52.08% return, which is significantly higher than CHRW's -7.48% return. Over the past 10 years, LGND has underperformed CHRW with an annualized return of 8.04%, while CHRW has yielded a comparatively higher 10.53% annualized return.
LGND
- 1D
- -2.95%
- 1M
- -10.02%
- 6M
- 49.68%
- YTD
- 52.08%
- 1Y
- 116.65%
- 3Y*
- 62.75%
- 5Y*
- 20.43%
- 10Y*
- 8.04%
- ALL TIME*
- 5.02%
CHRW
- 1D
- 0.55%
- 1M
- -22.19%
- 6M
- -23.70%
- YTD
- -7.48%
- 1Y
- 31.80%
- 3Y*
- 16.80%
- 5Y*
- 13.19%
- 10Y*
- 10.53%
- ALL TIME*
- 13.99%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $526.07M | $418.85M | $344.02M | |
| $90.15M | $100.41M | $98.25M |
LGND vs. CHRW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LGND Ligand Pharmaceuticals Incorporated | 52.08% | 76.45% | 50.03% | 6.92% | -56.75% | 55.31% | -4.64% | -23.15% | -0.90% | 34.76% |
CHRW C.H. Robinson Worldwide, Inc. | -7.48% | 59.01% | 22.89% | -3.10% | -13.09% | 17.22% | 22.95% | -4.71% | -3.63% | 24.56% |
Correlation
The correlation between LGND and CHRW is 0.20, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.20 |
Correlation (3Y) Balances recent behavior with more history. | 0.20 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.22 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.21 |
Correlation (All Time) Calculated using the full available price history since Oct 16, 1997 | 0.26 |
Fundamentals
LGND:
$5.76B
CHRW:
$17.41B
LGND:
$7.53
CHRW:
$5.23
LGND:
38.19
CHRW:
28.25
LGND:
0.33
CHRW:
5.26
LGND:
21.37
CHRW:
1.05
LGND:
5.73
CHRW:
10.92
LGND:
$274.48M
CHRW:
$17.00B
LGND:
$221.02M
CHRW:
$676.81M
LGND:
$253.90M
CHRW:
$909.95M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LGND vs. CHRW — Risk / Return Rank
LGND
CHRW
LGND vs. CHRW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ligand Pharmaceuticals Incorporated (LGND) and C.H. Robinson Worldwide, Inc. (CHRW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LGND | CHRW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.59 | ||
| Sortino ratioReturn per unit of downside risk | +2.60 | ||
| Omega ratioGain probability vs. loss probability | 1.49 | 1.19 | +0.30 |
| Calmar ratioReturn relative to maximum drawdown | 8.48 | 1.01 | +7.46 |
| Martin ratioReturn relative to average drawdown | 20.69 | 3.56 | +17.13 |
Loading charts...
Drawdowns
LGND vs. CHRW - Drawdown Comparison
The maximum LGND drawdown since its inception was -93.34%, which is greater than CHRW's maximum drawdown of -44.54%. Use the drawdown chart below to compare losses from any high point for LGND and CHRW.
Loading charts...
Drawdown Indicators
| LGND | CHRW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.34% | -44.54% | -48.80% |
Max Drawdown (1Y)Largest decline over 1 year | -14.07% | -29.84% | +15.77% |
Max Drawdown (3Y)Largest decline over 3 years | -29.91% | -30.59% | +0.68% |
Max Drawdown (5Y)Largest decline over 5 years | -70.11% | -40.55% | -29.56% |
Max Drawdown (10Y)Largest decline over 10 years | -81.94% | -40.55% | -41.39% |
Current DrawdownCurrent decline from peak | -10.87% | -29.46% | +18.59% |
Average DrawdownAverage peak-to-trough decline | -50.87% | -12.06% | -38.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.75% | 8.49% | -2.74% |
Volatility
LGND vs. CHRW - Volatility Comparison
The current volatility for Ligand Pharmaceuticals Incorporated (LGND) is 9.53%, while C.H. Robinson Worldwide, Inc. (CHRW) has a volatility of 21.50%. This indicates that LGND experiences smaller price fluctuations and is considered to be less risky than CHRW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LGND | CHRW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.53% | 21.50% | -11.97% |
Volatility (6M)Calculated over the trailing 6-month period | 28.41% | 36.66% | -8.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.37% | 46.91% | -10.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.03% | 33.69% | +10.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.47% | 29.60% | +15.87% |
Dividends
LGND vs. CHRW - Dividend Comparison
LGND has not paid dividends to shareholders, while CHRW's dividend yield for the trailing twelve months is around 1.70%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHRW C.H. Robinson Worldwide, Inc. | 1.70% | 1.55% | 2.38% | 2.82% | 2.47% | 1.93% | 2.17% | 2.57% | 2.24% | 2.03% | 2.38% | 2.53% |
LGND Ligand Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
LGND vs. CHRW - Financials Comparison
This section allows you to compare key financial metrics between Ligand Pharmaceuticals Incorporated and C.H. Robinson Worldwide, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LGND vs. CHRW - Profitability Comparison
LGND - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Ligand Pharmaceuticals Incorporated reported a gross profit of 0.00 and revenue of 51.72M. Therefore, the gross margin over that period was 0.0%.
CHRW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, C.H. Robinson Worldwide, Inc. reported a gross profit of -307.77M and revenue of 4.93B. Therefore, the gross margin over that period was -6.2%.
LGND - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Ligand Pharmaceuticals Incorporated reported an operating income of 17.37M and revenue of 51.72M, resulting in an operating margin of 33.6%.
CHRW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, C.H. Robinson Worldwide, Inc. reported an operating income of 255.74M and revenue of 4.93B, resulting in an operating margin of 5.2%.
LGND - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Ligand Pharmaceuticals Incorporated reported a net income of -13.35M and revenue of 51.72M, resulting in a net margin of -25.8%.
CHRW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, C.H. Robinson Worldwide, Inc. reported a net income of 186.79M and revenue of 4.93B, resulting in a net margin of 3.8%.
Frequently Asked Questions
LGND and CHRW have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CHRW has higher volatility (21.50%) compared to LGND (9.53%). In terms of maximum drawdown, LGND dropped -93.34% vs CHRW's -44.54%.
LGND currently has the higher Sharpe Ratio (3.29 vs 0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LGND and CHRW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer